tykhr
sign in
free sign up
Mereo BioPharma Group PLC ADR
Biotechnology
Healthcare
MREO
160 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.86
52 week high
4.69
high
1.88
52 week low
0.00
low
1.74
growth
-57.65 %
previous Close
1.85
P/E ratio
market cap
262 M
div yield
0
usd
Jun 2025
qoq
revenue
500 K
0.00 %
net incoming
-14.62 M
-13.42 %
eps
0.00 %
-32.45 %
eps surprise
17.70 %
net profit margin
-2923.20 %
-2923.00 %
operating incoming
-10.50 M
6.28 %
net change in cash
-6.36 M
22.72 %
cash on hand
56.13 M
-10.18 %
cost of revenue
132 K
0.00 %
top